214 related articles for article (PubMed ID: 18833545)
21. Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy.
Swanson MG; Zektzer AS; Tabatabai ZL; Simko J; Jarso S; Keshari KR; Schmitt L; Carroll PR; Shinohara K; Vigneron DB; Kurhanewicz J
Magn Reson Med; 2006 Jun; 55(6):1257-64. PubMed ID: 16685733
[TBL] [Abstract][Full Text] [Related]
22. Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy.
Cheng LL; Chang IW; Smith BL; Gonzalez RG
J Magn Reson; 1998 Nov; 135(1):194-202. PubMed ID: 9799694
[TBL] [Abstract][Full Text] [Related]
23. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
[TBL] [Abstract][Full Text] [Related]
24. Investigation of breast cancer using two-dimensional MRS.
Thomas MA; Lipnick S; Velan SS; Liu X; Banakar S; Binesh N; Ramadan S; Ambrosio A; Raylman RR; Sayre J; DeBruhl N; Bassett L
NMR Biomed; 2009 Jan; 22(1):77-91. PubMed ID: 19086016
[TBL] [Abstract][Full Text] [Related]
25. Metabolic alterations in the peritumoral brain in cases of meningiomas: 1H-MRS study.
Chernov MF; Nakaya K; Kasuya H; Kato K; Ono Y; Yoshida S; Nakamura R; Suzuki T; Muragaki Y; Iseki H; Kubo O; Hori T; Takakura K
J Neurol Sci; 2009 Sep; 284(1-2):168-74. PubMed ID: 19497588
[TBL] [Abstract][Full Text] [Related]
26. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication.
Jiménez B; Mirnezami R; Kinross J; Cloarec O; Keun HC; Holmes E; Goldin RD; Ziprin P; Darzi A; Nicholson JK
J Proteome Res; 2013 Feb; 12(2):959-68. PubMed ID: 23240862
[TBL] [Abstract][Full Text] [Related]
27. 1H and 13C HR-MAS spectroscopy of intact biopsy samples ex vivo and in vivo 1H MRS study of human high grade gliomas.
Martínez-Bisbal MC; Martí-Bonmatí L; Piquer J; Revert A; Ferrer P; Llácer JL; Piotto M; Assemat O; Celda B
NMR Biomed; 2004 Jun; 17(4):191-205. PubMed ID: 15229932
[TBL] [Abstract][Full Text] [Related]
28. Quantification of amounts and (13)C content of metabolites in brain tissue using high- resolution magic angle spinning (13)C NMR spectroscopy.
Risa O; Melø TM; Sonnewald U
NMR Biomed; 2009 Apr; 22(3):266-71. PubMed ID: 19012315
[TBL] [Abstract][Full Text] [Related]
29. Nucleoporin 88 expression in normal and neoplastic squamous epithelia of the uterine cervix.
Brustmann H; Hager M
Ann Diagn Pathol; 2009 Oct; 13(5):303-7. PubMed ID: 19751906
[TBL] [Abstract][Full Text] [Related]
30. Discrimination of patients with microsatellite instability colon cancer using 1H HR MAS MR spectroscopy and chemometric analysis.
Tessem MB; Selnaes KM; Sjursen W; Tranø G; Giskeødegård GF; Bathen TF; Gribbestad IS; Hofsli E
J Proteome Res; 2010 Jul; 9(7):3664-70. PubMed ID: 20507057
[TBL] [Abstract][Full Text] [Related]
31. Osteopontin expression correlates with invasiveness in cervical cancer.
Song JY; Lee JK; Lee NW; Yeom BW; Kim SH; Lee KW
Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):434-8. PubMed ID: 19694703
[TBL] [Abstract][Full Text] [Related]
32. Differences in expression of tumor markers between pre- and postmenopausal women with invasive cervical cancer.
Hellberg D; Tot T; Stendahl U
Anticancer Res; 2008; 28(3B):1793-5. PubMed ID: 18630462
[TBL] [Abstract][Full Text] [Related]
33. Epithelial and stromal metabolite changes in the transition from cervical intraepithelial neoplasia to cervical cancer: an in vivo 1H magnetic resonance spectroscopic imaging study with ex vivo correlation.
De Silva SS; Payne GS; Morgan VA; Ind TE; Shepherd JH; Barton DP; deSouza NM
Eur Radiol; 2009 Aug; 19(8):2041-8. PubMed ID: 19259678
[TBL] [Abstract][Full Text] [Related]
34. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
35. Metabolic profile of intact tissue from uterine leiomyomas using high-resolution magic-angle-spinning ¹H NMR spectroscopy.
Mazzei P; Piccolo A; Nugnes L; Mascolo M; De Rosa G; Staibano S
NMR Biomed; 2010 Dec; 23(10):1137-45. PubMed ID: 20623794
[TBL] [Abstract][Full Text] [Related]
36. Benign and atypical meningioma metabolic signatures by high-resolution magic-angle spinning molecular profiling.
Monleón D; Morales JM; Gonzalez-Darder J; Talamantes F; Cortés O; Gil-Benso R; López-Ginés C; Cerdá-Nicolás M; Celda B
J Proteome Res; 2008 Jul; 7(7):2882-8. PubMed ID: 18507434
[TBL] [Abstract][Full Text] [Related]
37. Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation.
Lehnhardt FG; Bock C; Röhn G; Ernestus RI; Hoehn M
NMR Biomed; 2005 Oct; 18(6):371-82. PubMed ID: 15959923
[TBL] [Abstract][Full Text] [Related]
38. Determination of metabolite concentrations in human brain tumour biopsy samples using HR-MAS and ERETIC measurements.
Martínez-Bisbal MC; Monleon D; Assemat O; Piotto M; Piquer J; Llácer JL; Celda B
NMR Biomed; 2009 Feb; 22(2):199-206. PubMed ID: 18833546
[TBL] [Abstract][Full Text] [Related]
39. [Progress in nuclear magnetic resonance spectroscopy for early cancer diagnosis].
Gao XX; Xu YZ; Zhao MX; Qi J; Li HZ; Wu JG
Guang Pu Xue Yu Guang Pu Fen Xi; 2008 Aug; 28(8):1942-50. PubMed ID: 18975839
[TBL] [Abstract][Full Text] [Related]
40. Quantitative (31)P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts.
Esmaeili M; Bathen TF; Engebråten O; Mælandsmo GM; Gribbestad IS; Moestue SA
Magn Reson Med; 2014 Jun; 71(6):1973-81. PubMed ID: 23878023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
